Last reviewed · How we verify

NCT05113732

Association of Cognition With Functional Mobility in People With Alzheimer's Disease

Status unknown Last updated 9 November 2021
What this trial tests

trial in Alzheimer Dementia in 64 participants. Status unknown.

Timeline
1 November 2021
Primary endpoint
1 January 2022
1 May 2022

Quick facts

Lead sponsorIstanbul University - Cerrahpasa
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment64
Start date1 November 2021
Primary completion1 January 2022
Estimated completion1 May 2022
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University - Cerrahpasa

Who can join

Eligibility, any sex, with Alzheimer Dementia or Alzheimer's Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate relationship between cognitive function and functional mobility in Alzheimer's disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Alzheimer Dementia

Currently open trials in the same condition.

Other Istanbul University - Cerrahpasa trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05113732.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing